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Visual neglect (VN) is a common consequence of right hemisphere (RH) stroke. The aims of this study were to explore the presence
of VN after RH stroke in the patients with (T+) or without (T−) thrombolytic treatment, and to determine whether thrombolysis
is a predictor of VN. The study group consisted of 77 RH infarct patients. VN was evaluated with six conventional subtests of the
Behavioural Inattention Test (BIT). Stroke severity was assessed using the National Institute of Health Stroke Scale (NIHSS). In
the neuropsychological examination, 22% of all RH stroke patients had VN. VN was present in 15% of the patients in the T+
group and in 28% of the patients in the T− group, but the diﬀerence was not statistically significant. Despite that, patients in the
T− group had a higher risk of VN than patients in the T+ group. Our results suggest that thrombolysis independently predicted
absence of VN.
1. Introduction
Previous studies have confirmed that visual neglect (VN) is a
common consequence of right hemisphere (RH) stroke [1–
5]. The prevalence of VN has been studied extensively, and
the results of this work are summarized in a review by Bowen
et al. [1]. According to Bowen et al. [1], the median reported
prevalence of neglect in RH patients is 43%. The presence of
neglect implies a poor prognosis in terms of discharge time,
length of hospital stay, and functional recovery [6–8].
Previous studies [9, 10] have shown that patients who
receive thrombolytic treatment within the first three hours of
ischemic stroke can expect a favourable or good three-month
clinical outcome. The benefit of thrombolytic treatment is
thought to be due to vessel recanalization resulting in restitu-
tion of blood flow to ischemic regions of brain [11, 12] which
leads to neurological improvement, smaller infarct size, and
better clinical outcome [13].
Association between thrombolytic treatment and neu-
ropsychological outcomes, particularly VN in the early phas-
es of stroke, has so far received only limited attention. Recent
studies suggest that thrombolytic treatment is a significant
predictor of earlier discharge to home in patients with mod-
erate/severe RH infarct [14], and it is related to a favourable
eﬀect on visuoperceptual functions [15]. Nys et al. [16]
found evidence of favourable eﬀect on functional outcome
but no eﬀects on any cognitive domain during the 6–10
month followup. They suspected that thrombolytic treat-
ment has a short-term influence on cognitive outcome, but
this eﬀect is not sustained or it disappears in long-term
followups.
The association between thrombolytic treatment and
cognitive functions, particularly VN following RH brain in-
farct, has not been previously studied. The aims of this study
were to explore the presence of VN after RH stroke in the
patients with (T+) or without (T−) thrombolytic treatment
and to determine whether thrombolysis is a predictor of VN.
2. Patients and Methods
2.1. Patients. We screened 1,458 consecutive patients who
were admitted to a university hospital as emergency cases
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between June 2005 and June 2008. Patients were eligible for
inclusion if they had a first-ever ischemic RH stroke. Exclu-
sion criteria were previous history of neurological, cognitive
or psychiatric disorders, alcohol abuse, severe primary visual
or auditory impairment, left-handedness, decreased level of
consciousness, preexistent dependence on activities of daily
living, and age over 80 years. Figure 1 shows the number of
patients who were included in this study and the number of
who were excluded.
The study was approved by the Ethical Committee of the
University Hospital. During their hospital stay all patients
received standard treatment. Informed consent was obtained
from all participating patients.
2.2. Methods
2.2.1. Neuropsychological Examination. The neuropsycho-
logical examination was conducted on each patient on aver-
age four days (range: 1–11 days) after onset. The general cog-
nitive function was evaluated with the Mini Mental State
Examination (MMSE) [17]. Presence of VN was evaluated
with the six conventional paper-and-pencil subtests of the
Behavioural Inattention Test (BITC) [18]. BITC includes
three target cancellation tasks, figure and shape copying,
line bisection, and representational drawing. Maximum total
score is 146. Patients scoring at or below the cut-oﬀ point
(≤129) for total BITC score or below the cut-oﬀ score on at
least two of the six BITC subtests were considered to have
VN. For each subtest, we used the same cut-oﬀ points as
Halligan et al. [19].
2.2.2. Stroke Severity and Computerized Tomography. To de-
fine stroke severity, degree of motor defects, and presence of
hemianopia, we used the National Institute of Health Stroke
Scale (NIHSS) [20]. NIHSS was scored before treatment on
arrival at the emergency department (NIHSS at baseline),
and later on the neurological ward on average four days
(range: 1–10) after onset (NIHSS at neurological ward).
Hemiparesis was scored using a scale from 0 (= normal) to 4
(= severe hemiparesis) for leg and arm separately, and these
scores were then summed. Hemianopia was assessed using
standardized neurological confrontation technique and was
scored as absent (0) or present (1).
At the acute stage of stroke, a computerized tomography
(CT) of the brain was performed to detect the site of the
lesion. Within the first three hours of stroke, thrombolytic
treatment was administered as recommended in the National
Institute of Neurological Disorders and Stroke study [21].
2.3. Statistical Analyses. Since some of the parameters were
not normally distributed and the sample sizes were small, we
chose to use nonparametric tests for continuous variables.
Diﬀerences between the T+ and the T− groups in continuous
variables were analyzed using theMann-Whitney U test. Cat-
egorical variables were compared using crosstabulations.
Logistic regression analysis was used to adjust the asso-
ciation between thrombolytic treatment and VN for other
possible factors. In this analysis, thrombolytic treatment,
NIHSS at baseline, age, years of education, and gender were
used as independent variables and VN as the dependent vari-
able. The results are presented as odds ratios (OR) with cor-
responding 95% confidence intervals (95% CI). Statistical
significance was set at 0.05 for all analyses. All reported P
values are based on two-tailed tests.
3. Results
After application of these exclusion criteria, the final study
group consisted of 77 right-handed RH brain infarct pa-
tients, 34 received thrombolytic treatment. Patients were
divided into the two groups (T− versus T+), and groups did
not diﬀer statistically significantly in age, gender, years of
education, MMSE, days from onset to neuropsychological or
neurological examinations, and presence of hemianopia or
hemiparesis. The details of clinical characteristics are shown
in Table 1.
3.1. The Presence of Visual Neglect. In the neuropsychological
examination, 22% of all RH stroke patients had VN. VN
was present in 15% of the patients in the T+ group and in
28% of the patients in the T− group, but the diﬀerence was
not statistically significant (P = 0.168). Logistic regression
analysis showed that thrombolytic treatment independently
predicted absence of VN after adjusting for years of educa-
tion, gender, age, and NIHSS at baseline. RH patients with-
out thrombolytic treatment had a higher probability of VN
than those with thrombolytic treatment (OR = 4.366; 95%
CI, 0.994 to 19.175: P = 0.05) after adjusting for other fac-
tors.
3.2. Stroke Severity. On admission to the emergency depart-
ment, the T+ group showed more severe stroke in NIHSS
than the T− group, but this diﬀerence was not statistically
significant (P = 0.137). A statistically significant diﬀerence
was found between the T− and the T+ groups in NIHSS
(P = 0.009) on average four days after onset, indicating that
patients in the T− group had more severe stroke than pa-
tients in the T+ group.
4. Discussion
This study was conducted among a homogenous group of
consecutive RH ischemic stroke patients. The main aims of
this study were to explore the presence of VN after RH stroke
in the patients with (T+) or without (T−) thrombolytic
treatment, and to determine whether thrombolysis is a pre-
dictor of VN.
According to the neuropsychological examination, VN
was present in 15% of the patients in the T+ group and in
28% in the T− group, but this diﬀerence did not reach sta-
tistical significance. Thrombolytic treatment independently
predicted absence of VN, and therefore patients in the T−
group had a higher probability of VN. NIHSS baseline scores
did not diﬀer significantly between the T+ and the T−
groups, but after average four days from onset the T− group
had statistically significantly higher NIHSS values than the
T+ group.











1,458 consecutive patients were 
screened
95% of all patients were excluded: left hemisphere stroke
(n = 276), transient ischemic attack (n = 200), previous stroke
(n = 185), age over 80 years (n = 144), cerebral haemorrhage
(n = 139), other neurological diagnosis (n = 137), not able to
participate in neuropsychological examination (n = 95 patients),
significant findings in CT not related to acute stroke (n = 92), brain
stem or cerebellar stroke (n = 57), substance abuse (n = 21),
psychiatric disorder (n = 20), traumatic brain injury (n = 6), left-
handedness (n = 5), and native language other than Finnish (n = 4).
43 RH T− 34 RH T+
31 nonneglect 29 nonneglect
Figure 1: Selection of acute ischemic right hemisphere (RH) stroke patients with (T+) or without (T−) thrombolytic treatment.
There are no earlier reports on the presence of VN after
thrombolytic treatment at the acute phase of stroke. Nys et al.
[16] did not find an eﬀect of thrombolytic treatment on any
cognitive domain after a minimum of a six-month followup,
and they concluded that thrombolytic treatment is associ-
ated only with basic functional outcome in the followup.
Furthermore, they speculated that thrombolytic treatment
might have a short-term influence on cognitive function, but
this eﬀect is not sustained at later followup. In our study, we
found that thrombolytic treatment had a favourable eﬀect on
VN in the very early stages of stroke. Patients in the T− group
had a higher risk of VN after average four days from onset
than patients in the T+ group.
We found that the presence of VN in the T+ group after
RH stroke was lower than indicated in previous studies.
According to Bowen et al. [1], the median reported preva-
lence of neglect in RH patients is 43%. In our study, only
15% of the T+ patients had VN, whereas Jehkonen et al. [2]
reported that the presence of VN in the acute phase was 38%.
The exclusion criteria, research setting, and the methods
used to assess VN in the study of Jehkonen et al. [2] are
identical to those in the present study, but at the time of that
earlier study thrombolytic treatment was not available at our
hospital.
VN was present in 28% of acute RH stroke patients with-
out thrombolytic treatment. Earlier studies on the presence
of VN without thrombolytic treatment have reported figures
that vary widely from 13% to 82%: this is explained by differ-
ences in patient selection criteria, time elapsed since stroke,
and the methods used in assessing VN [1]. The diﬀerences in
the sensitivity of neglect tests [19, 22] and the reported pres-
ence of neglect depend on the methods used [23, 24]. Our
study was conducted among a homogenous group of con-
secutive RH stroke patients, and the time elapsed since stroke
until assessment of VN did not diﬀer statistically between the
T+ and the T− groups. The presence of VN was assessed
in each patient on average four days after onset using six
standardised subtests of the BITC. In the study by Nys et al.
[16], the assessment of VN was based on a single task, and
they did not report the presence of neglect in the acute phase
of stroke. In the study by Di Legge et al. [25], neglect was
detected with NIHSS, which includes only one item to evalu-
ate neglect. It has earlier been confirmed [19, 23] that one
test is not enough to determine the presence of neglect.
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Table 1: Clinical characteristics of patients with (T+) and without thrombolysis (T−) and the comparison between the groups.
T+ (n = 34) T– (n = 43) P value
Male/Female 19/15 31/12 0.090
Age: Md (range) 60.5 (30–77) 62.0 (36–79) 0.252
Education in years: Md (range) 10.0 (6–16) 9.0 (6–20) 0.278
MMSE: Md (range) 27.5 (20–30) 27 (21–30)a 0.731
Neuropsychological
examination (days): Md (range)
5.0 (1–10) 3.0 (1–11) 0.798
Neurological examination
(days): Md (range)
5.0 (1–10)b 3.0 (1–10)a 0.305
(a) Baseline measures
NIHSS: Md (range) 6.0 (1–17) 4.0 (1–15) 0.137
Hemianopia: present (%) 5 (16)a 6 (14) 0.841
Hemiparesis: present (%) 26 (76) 30 (70) 0.515
(b) Measures at ward
BITC: Md (range) 143.5 (38–146) 142 (31–146) 0.150
BITC: VN present (%) 5 (15) 12 (28) 0.168
NIHSS: Md (range) 1 (0–17)a 3 (0–14)b 0.009
Hemianopia: present (%) 5 (15)b 5 (12)c 0.745
Hemiparesis: present (%) 11 (33)b 17 (40)c 0.426
Abbreviations: Md: median; BITC: sum score of six conventional subtests of the Behavioural Inattention Test (range 0–146; ≤129 = visual neglect, ≥130 = no
visual neglect); MMSE: Mini Mental State Examination (range 0–30); Neuropsychological examination: days from onset to neuropsychological examination;
neurological examination: days from onset to neurological examination; VN: visual neglect; NIHSS: sum score of the National Institute of Health Stroke Scale
(range: 0–34; 0 = no defect; 34 = severe stroke); at baseline: outcome on admission in the emergency department; at ward: outcome at neurological ward;
amissing value for one patient; bthree patients had missing values; cfour patients had missing values.
A comprehensive assessment of VN must include diﬀerent
types of measures. The evaluation of VN in the acute phase
of stroke before and after thrombolytic treatment must rely
on standardized methods, and it is also necessary to followup
the patients.
According to Pedersen et al. [4], the presence of neglect is
associated with the severity of stroke. Our results here were
similar: after four days from onset, NIHSS scores were lower
in the T+ group than in the T− group, and similarly VN was
more common in the T− group than in the T+ group (28%
versus 15%). Baseline NIHSS on admission did not diﬀer
statistically significantly between the two groups, but their
sum scores for stroke severity were diﬀerent (median NIHSS
score: 6 versus 4). NIHSS scores improved more between
admission and four days after onset in the T+ group than in
the T− group (median NIHSS score: 6 to 1 versus 4 to 3).
The main strength of this study is that it was carried out
in a homogeneous group of consecutive RH patients who
had suﬀered their first brain infarct. Secondly, the presence of
VN was assessed in each patient using a systematic battery of
standard paper-and-pencil tasks [18] which is in widespread
clinical use and focused on assessing extrapersonal neglect
in near space. One limitation is the small number of stroke
patients in the subgroups. Furthermore, we only investigated
RH stroke patients, which means that the results cannot be
generalized to the whole stroke population.
Despite these limitations, our results indicate that the
administration of thrombolytic treatment within the first
three hours of RH stroke decreases the risk of VN. The
presence of VN after RH stroke without thrombolytic treat-
ment was 28% and with thrombolytic treatment 15%. We
conclude that VN occurs more often in RH infarct patients
who do not receive thrombolytic treatment than in those
who do receive thrombolytic treatment within the first three
hours of first-ever brain infarct, but further research is need-
ed to confirm this result.
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